Radiobiology 2016

ARCON A ccelerated R adiotherapy + C arbOgen + N icotinamide

Tumor cell proliferation

Chronic hypoxia

Acute hypoxia

S

S

D

S

S

D

S S

D

D

D

S

S S

S

S

S D S

S S S

S

D

S

S

D

D

S

S

S

D

S

S

S

D

S

S

S

S

S

D

D D D

S S S

S

S

S

S

S

S S

D

D

S

S

S

S S S S

D S

S

D

S

S

D

S

S

S

S

D

S

D D

D

S

D

S

D

S

S

S

S S

S

S

S

D

S

D

S

S S

D

S

S

S S

D

D

D D

S

D

D

D

S

S

S

D D

S S

D

D

S

D

S

S

D

S

S

S

S

S

D D

S

S S

D

S

D

S

S

S

D

S

S

S

S

S

S

D

S

D

D

S S S

D

D

S

S

S

D

D

S

S

S

S S S

D

S

S

S

D

S

S S S

D

S

S

D D

D

S

D

S

S

S

D

D

D D

S

S S

S

S

S

S

S

D

S

D D

D

S S

S

Carbogen

D D

D

Nicotinamide

98% O

+ 2% CO 2

2

Accelerated fractionation

S

S

D

S

S S S S S S D

D

S S

D

D

S

S

S D S

S S S

S

D

S

S

D

D

S

D

S

S

S

D

S

S

S

S

S

stem cell differentiated cell

S

D